期刊文献+

黄芪等12味中药在体外培养中对人调节性T细胞分化的影响 被引量:15

Effects of twelve Chinese herbs on human regulatory T cell differentiation in vitro
下载PDF
导出
摘要 目的:探讨黄芪等12味中药对人调节性T细胞的分化的影响,为溃疡性结肠炎的中药组方研究提供实验依据.方法:分离正常人外周血淋巴细胞和单核细胞,在体外培养中用人肠道厌氧菌抗原刺激单核细胞,然后将激活的单核细胞与淋巴细胞混合培养,分别加入黄芪等12种不同的中药煎液,最后用流式细胞术检测其对CD4+CD25+FOXP3+调节性T细胞分化的影响.结果:与PBS组比较,CD4+细胞中CD25及FOXP3双阳细胞的百分比在黄芪及丹参组明显升高(5.6%±0.6%,5.5%±0.8%vs4.3%±0.8%;均P<0.01),同时CD4+CD25+细胞中FOXP3的表达率也显著升高(50.0%±3.8%,45.1%±3.3%vs30.9%±4.5%;均P<0.01).结论:黄芪和丹参可能通过调节性T淋巴细胞的分化平衡来发挥其治疗作用,可作为溃疡性结肠炎组方的首选中药. AIM: To investigate the effects of 12 Chinese herbals (including Astragalus) on the differentiation of human regulatory T cells, and to provide experimental basis for the treatment of ulcerative colitis (UC) using traditional Chinese medicine (TCM). METHODS: Normal human peripheral lymphocytes and monocytes were seperated and cultured in vitro. The monocytes challenged by anaerobic intestinal bacterial antigens were cocultured with lymphocytes and then treated with 12 different decoctions of Chinese herbs including Astragalus. Flow cytometry was used to detect the differentiation of CD4^±CD25^±FOXP3^± regulatory T cells. RESULTS: As compared with that in the PBS control group, CD4^±CD25^±FOXP3^± regulatory T cell population increased significantly in the Astragalus-treated group and Salvia-treated group (5.6% ± 0.6%, 5.5% ± 0.8% vs 4.3% ± 0.8%; both P 〈 0.01), and FOXP3^± expression in CD4^±CD25^± cells increased significantly as well (50.0% ± 3.8%, 45.1% ± 3.3% vs 30.9% ± 4.5%; both P 〈 0.01). CONCLUSION: Salvia Miltiorrhiza and Astragalus may be the first choice for the treatment of ulcerative colitis due to their regulatory effects on the balance of T lymphocyte differentiation.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第24期2770-2774,共5页 World Chinese Journal of Digestology
关键词 溃疡性结肠炎 炎症性肠病 T淋巴细胞 黄芪 丹参 中药 Ulcerative colitis Inflammatory bowel disease T lymphocyte Astragalus Salvia Miltior- rhiza Chinese traditional medicine
  • 相关文献

参考文献15

  • 1Zheng JJ. Incidence of inflammatory bowel disease. In: Zheng JJ, Chu XQ. Inflammatory bowel disease: basis and clinic. Beijing: Science Press, 2001:36 被引量:1
  • 2Jani N, Regueiro MD. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 2002; 31:147-166 被引量:1
  • 3欧阳钦.对加强炎症性肠病临床研究的意见[J].中华消化杂志,2001,21(4):197-198. 被引量:11
  • 4田海河.中药治疗溃疡性结肠炎的临床及实验研究[J].北京中医药大学学报,1995,18(5):47-49. 被引量:8
  • 5Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307:1920-1925 被引量:1
  • 6Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005; 54:317-320 被引量:1
  • 7Powrie F. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann N Y Acad Sci 2004; 1029:132-141 被引量:1
  • 8Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007,117:514-521 被引量:1
  • 9Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis 2004; 10:666-676 被引量:1
  • 10Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585-598 被引量:1

二级参考文献6

共引文献16

同被引文献226

引证文献15

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部